Class of 2027 launches medical journey with white coats

Members of the Weill Cornell Medicine Class of 2027 received their short white coats on Aug. 15 during the annual White Coat Ceremony, officially marking the beginning of their medical education.

Technique shows how abnormal RNA splicing leads to disease

A technique that enables scientists to record gene mutations and patterns of gene activity in individual cells has been extended to cover RNA splicing as well, in a study co-led by researchers at Weill Cornell Medicine.

‘Trashbots’ help Brooklynites clean up, connect

Cornell Tech researchers deployed “trashbots” in Brooklyn for two weeks in July. The goal of the experiment was to see how people interact with, and make sense of, service robots in public spaces. The cleaning was an added bonus.

Gene-editing tool helps target small cancer-linked mutations

A new gene-editing tool created by Weill Cornell Medicine investigators will enable cancer researchers to study the impact of specific genetic changes in preclinical models.

COVID boosters show value for those pregnant or trying to conceive

Pregnant women who had a previous COVID-19 infection and received full vaccination and a booster have the strongest immune protection from the disease – and pass that protection along to their unborn babies, according to a new study.

Using broad race categories in medicine hides true health risks

Many medical studies record a patient’s race using only the broad categories from the U.S. Census, which may conceal racial health disparities, a new Cornell-led study reports.

Potential neuropathic pain treatment shows promise in preclinical tests

A non-opioid designer molecule for treating chronic neuropathic pain has had promising results in a preclinical study conducted by researchers at Weill Cornell Medicine and the Burke Neurological Institute.

Hep C treatment initiation low among Medicaid recipients

Only one in five Medicaid enrollees diagnosed with hepatitis C virus started treatment, according to a retrospective study led by researchers at Weill Cornell Medicine and Cornell University’s Ithaca campus.

Cornell introduces new AI-focused Board Governance program

Board Governance: Navigating Emerging Technologies and More in a Complex World, a new Cornell Tech immersion program, is set to prepare corporate board members for fast-paced evolutions driving the future of commerce.

Around Cornell